A survey of the quality of web based information on the treatment of schizophrenia and attention deficit hyperactivity disorder

Australian and New Zealand Journal of Psychiatry

Volumn 37, Issue 1, 2003, Pages 85-91

  Kisely, Stephen ^a   Ong, Greg ^b   Takyar, Ashish ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Attention deficit hyperactivity disorder; Internet; Schizophrenia; World wide web

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HUMAN; INTERNET; MEDICAL INFORMATION SYSTEM; METHODOLOGY; QUALITY CONTROL; RELIABILITY; SCHIZOPHRENIA; SCORING SYSTEM; STANDARDIZATION; STATISTICAL ANALYSIS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION; EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; INTERNET; QUESTIONNAIRES; READING; SCHIZOPHRENIA;

EID: 0037303780     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2003.01107.x     Document Type: Article

References (39)

1. Pealer LN, Dorman SM. Evaluating health related Web sites. Journal of School Health 1997; 67:232-235.
2. Jadad AR, Gagliardi A. Rating health information on the Internet: navigating to knowledge or to babel. Journal ofthe American Medical Association 1998; 279:611-614.
3. Kim P, Eng TR, Deering MJ, Maxfield A. Published criteria for evaluating health-related web sites. British Medical Journal 1999; 318:647-649.
4. Silberg WM, Lundberg GD, Musacchio RA. Accessing, controlling and assuring the quality of medical information on the internet. Journal of the American Medical Association 1993; 277:1244-1245.
5. Health On the Net Foundation. Code of conduct for medical and health web sites. [Cited 3 October 2001.] Available from URL: http://www.hon.ch/HONcode/Conduct.html
6. Eysenbach G, Powell J, Kuss O, SaE-R. Empirical studies assessing the quality of health information for consumers on the World Wide Web: a systematic review. Journal of the American Medical Association 2002; 287:2691-2700.
7. Griffiths K, Christensen H. Quality of web based information on treatment of depression: cross sectional survey. British Medical Journal 2000; 321:1511-1515.
8. Griffiths K, Christensen H. The quality and accessibility of Australian depression sites on the World Wide Web. Medical Journal of Australia 2002; 176:S97-S 104.
9. Berland GK, Elliott MN, Morales LS et al. Health information on the internet: accessibility, quality and readability in English and Spanish. Journal of the American Medical Association 2001; 285:2612-2621.
10. Impicciatore P, Pandolfibi C, Casella N, Bonati M. Reliability of health information for the public on the world wide web: systematic survey of advice on managing fever in children at home. British Medical Journal 1997; 314:1875-1881.
11. Soot LC, Moneta GL, Edwards JM. Vascular surgery and the Internet: a poor source of patient-oriented information. Journal of Vascular Surgery 1999; 30:84-91.
12. Miles J, Petrie C, Steel M. Slimming on the Internet. Journal of the Royal Society of Medicine 2000; 93:254-257.
13. Wyatt JC. Measuring quality and impact of the world wide web. British Medical Journal 1997; 314:1879-1881.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association, 1994.
15. Abbott VP. Web page quality: can we measure it and what do we find? A report of explanatory findings. Journal of Public Health Medicine 2000; 22:191-197.
16. Charnock D, ed. The DISCERN handbook. Oxford: Radcliffe Medical Press, 1998.
17. The Health Summit Working Group. IQ tool. [Cited 3 October 2001.] Available from URL: http://hitweb.mitretek.org/iq/default.asp
18. Leucht S, Pitschel-Walz G, Abraham D, Kissling W. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomised controlled trials. Schizophrenia Research 1999, 2002; 35:51-68.
19. Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders. (Cochrane Review). In: The Cochrane Library 1. Oxford: Update Software, 2002.
20. Pekkala E, Merinder L. Psychoeducation for schizophrenia. (Cochrane Review). In: The Cochrane Library 1. Oxford: Update Software. 2002.
21. Jones C, Cormac I, Mota J, Campbell C. Cognitive behaviour therapy for schizophrenia (Cochrane Review). In: The Cochrane Library 1. Oxford: Update Software, 2002.
22. Pharoah FM, Mari JJ, Streiner D. Family intervention for schizophrenia (Cochrane Review). In: The Cochrane Library, 1. Oxford: Update Software, 2002.
23. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. [Cited 5 April 2001.] Available from URL: http://www.psych.org/clin_res/_schizo.cfm
24. Western Australian Psychotropic Drugs Subcommittee. Psychotropic drug guidelines. Perth: Western Australian Drugs and Therapeutics Committee, Health Department of Western Australia, 2000.
25. Scottish Intercollegiate Guidelines Network. Attention deficit and hyperkinetic disorders in children and young people. Edinburgh: Royal College of Physicians, 2001.
26. National Institutes for Health. Diagnosis and treatment of Attention Deficit Hyperactivity Disorder. NIH Consensus Statement 1998; 16:1-37.
27. Lord J, Paisley S. The clinical effectiveness and cost-effectiveness of methylphenidate for hyperactivity in childhood. London: National Institute for Clinical Excellence, 2000.
28. Ohio State University. Revising and editing with word: spelling, grammar, and style. [Cited 3 October 2001.] Available from URL: http://ccl.english.ohio-state.edu/handouts/Word/ revision⊃ellàmc̄.htm
29. Ong G, Takyar A, Kisely S. Explanation of operationalised criteria. [Cited 8 February 2002.] Available from URL: http://www.geocities.com/skisely/index.html
30. Media Metrix. Media Metrix. [Cited 5 April 2001.] Available from URL: http://www.mediametrix.com/landing.jsp
31. Kisely S, Ong G, Takyar A. Details of web sites. [Cited 8 February 2002.] Available from URL: http://www.geocities.com/skisely/websites.html
32. Winker MA, Flanagin A, Chi-Lum B et al. Guidelines for medical and health information sites on the internet: principles governing AMA web sites. American Medical Association. Journal of the American Medical Association 2000; 283:1600-1606.
33. Internet Healthcare Coalition. Code of ethics. [Cited 3 October 2001.] Available from URL: http://www.ihealthcoalition.org/ethics/ethics.htm
34. Netscoring. Netscoring. [Cited 3 October 2001.] Available from URL: http://www.chu-rouen.fr/netscoring/html
35. European Union. MedCertain. [Cited 3 October 2001.] Available from URL: http://www.medcertain.org.html
36. Hi-Ethics. Hi-Ethics. [Cited 3 October 2001.] Available from URL: http://www.hiethics.com
37. University of Nottingham. Organising Medical Network Information (OMNI). [Cited 3 October 2001.] Available from URL: http://omni.ac.uk
38. United States Department of Health and Human Services. Healthfinder. [Cited 3 October 2001.] Available from URL: http://www.healthfinder.gov/
39. Eysenbach G, Diepgen T. Towards quality management of medical information on the Internet. British Medical Journal 1998; 317:1496-1502.